Matinas BioPharma Holdings, Inc. (MTNB)
2.64
+0.22
(+9.09%)
USD |
NYAM |
Oct 02, 16:00
2.83
+0.19
(+7.20%)
After-Hours: 20:00
Matinas BioPharma Holdings Market Cap : 1.128M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 1.128M |
| October 01, 2026 | 1.034M |
| September 30, 2026 | 1.089M |
| September 29, 2026 | 1.23M |
| September 28, 2026 | 1.081M |
| September 25, 2026 | 1.025M |
| September 24, 2026 | 1.140M |
| September 23, 2026 | 1.121M |
| September 22, 2026 | 17.01M |
| September 21, 2026 | 16.71M |
| September 18, 2026 | 15.41M |
| September 17, 2026 | 15.66M |
| September 16, 2026 | 15.86M |
| September 15, 2026 | 15.37M |
| September 14, 2026 | 18.45M |
| September 11, 2026 | 17.78M |
| September 10, 2026 | 19.70M |
| September 09, 2026 | 17.65M |
| September 08, 2026 | 17.49M |
| September 04, 2026 | 17.49M |
| September 03, 2026 | 17.39M |
| September 02, 2026 | 17.87M |
| September 01, 2026 | 19.00M |
| August 31, 2026 | 19.00M |
| August 28, 2026 | 19.22M |
| Date | Value |
|---|---|
| August 27, 2026 | 19.22M |
| August 26, 2026 | 18.87M |
| August 25, 2026 | 18.96M |
| August 24, 2026 | 18.88M |
| August 21, 2026 | 19.10M |
| August 20, 2026 | 17.54M |
| August 19, 2026 | 23.16M |
| August 18, 2026 | 19.57M |
| August 17, 2026 | 21.35M |
| August 14, 2026 | 22.49M |
| August 13, 2026 | 22.39M |
| August 12, 2026 | 23.06M |
| August 11, 2026 | 25.18M |
| August 10, 2026 | 25.85M |
| August 07, 2026 | 27.19M |
| August 06, 2026 | 25.79M |
| August 05, 2026 | 26.43M |
| August 04, 2026 | 27.91M |
| August 03, 2026 | 28.98M |
| July 31, 2026 | 28.23M |
| July 30, 2026 | 30.50M |
| July 29, 2026 | 28.63M |
| July 28, 2026 | 28.16M |
| July 27, 2026 | 31.90M |
| July 24, 2026 | 23.20M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
| Biogen, Inc. | 32.48B |
Market Cap Related Metrics
| Price to Book Value | 0.6264 |
| Price | 2.64 |
| Earnings Yield | -682.3% |